ArticlePharmaceuticals (Basel, Switzerland)2025

Bevacizumab in Platinum-Sensitive Recurrent Epithelial Ovarian Cancer: A Risk-Stratified Analysis.

İrem Öner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.